MARKET

ENTX

ENTX

Entera
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.760
-0.040
-2.22%
After Hours: 1.760 0 0.00% 18:54 07/10 EDT
OPEN
1.770
PREV CLOSE
1.800
HIGH
1.813
LOW
1.760
VOLUME
11.60K
TURNOVER
--
52 WEEK HIGH
3.770
52 WEEK LOW
1.350
MARKET CAP
32.09M
P/E (TTM)
-2.2432
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ENTX stock price target is 12.80 with a high estimate of 17.60 and a low estimate of 8.00.

EPS

ENTX News

More
Entera Bio Ltd Provides Update on Phase 2 Clinical Trial of EB613 in Postmenopausal Women With Osteoporosis
GlobeNewswire · 5d ago
Entera Bio Receives IRB Approval For Amended Phase 2 Protocal With Newly Enrolled Patients Of EB613 For Postmenopausal Women With Osteoporosis
Entera Bio Ltd Provides Update on Phase 2 Clinical Trial of EB613 in Postmenopausal Women With Osteoporosis ‒ Institutional Review Boards (IRBs) Approve Amended Phase 2 Protocol with Newly Enrolled Patients Receiving a
Benzinga · 5d ago
Kadmon Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 05/23 17:52
30 Stocks Moving in Friday's Pre-Market Session
Gainers Navidea Biopharmaceuticals, Inc. (NASDAQ: NAVB) shares rose 65.2% to $2.18 in pre-market trading after the company reported results of second interim analysis of ongoing Phase 2B study in rheumatoid arthritis.
Benzinga · 05/22 11:18
64 Biggest Movers From Yesterday
Gainers
Benzinga · 05/22 09:26
Entera Bio down 25% on underwhelming data on osteoporosis candidate
Ultra-thinly traded nano cap Entera Bio (ENTX -24.6%) slumps on a 35x surge in volume, albeit on turnover of only 327K shares, in reaction to preliminary r
seekingalpha · 05/21 20:42
Mid-Afternoon Market Update: Dow Falls 50 Points; L Brands Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 0.20% to 24526 while the NASDAQ fell 0.56% to 9323.26. The S&P also fell, dropping 0.51% to 2956.56.
Benzinga · 05/21 18:30
51 Stocks Moving In Thursday's Mid-Day Session
Gainers Seneca Biopharma, Inc. (NASDAQ: SNCA) jumped 99% to $1.6350.
Benzinga · 05/21 17:18

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About ENTX

Entera Bio Ltd is an Israel-based product-focused biotechnology company that specializes in the oral delivery of large molecules and biologics. The Company conducts clinical trials on its proprietary technology, which allows oral delivery of large molecules and biologics while enhancing their absorption in the gastrointestinal (GI) tract. Entera Bio Ltd's technology addresses the major problems of oral drug delivery of large molecule active pharmaceutical ingredients (APIs). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract. The Company’s proprietary technologies act synergistically to transport and protect large molecules. The Company develops drugs for hypoparathyroidism, osteoporosis and bone healing.
More

Webull offers kinds of Entera Bio Ltd stock information, including NASDAQ:ENTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ENTX stock methods without spending real money on the virtual paper trading platform.